(ARMK) Aramark Holdings - Ratings and Ratios

Exchange: NYSE • Country: United States • Currency: USD • Type: Common Stock • ISIN: US03852U1060

Food, Facilities, Catering, Dining, Services

ARMK EPS (Earnings per Share)

EPS (Earnings per Share) of ARMK over the last years for every Quarter: "2020-09-30": -0.35, "2020-12-31": -0.31, "2021-03-31": -0.24, "2021-06-30": 0.03, "2021-09-30": 0.21, "2021-12-31": 0.22, "2022-03-31": 0.22, "2022-06-30": 0.25, "2022-09-30": 0.48, "2022-12-31": 0.41, "2023-03-31": 0.28, "2023-06-30": 0.36, "2023-09-30": 0.64, "2023-12-31": 0.41, "2024-03-31": 0.29, "2024-06-30": 0.31, "2024-09-30": 0.54, "2024-12-31": 0.51, "2025-03-31": 0.34, "2025-06-30": 0.4,

ARMK Revenue

Revenue of ARMK over the last years for every Quarter: 2020-09-30: 2692.15, 2020-12-31: 2743.789, 2021-03-31: 2819.692, 2021-06-30: 2981.22, 2021-09-30: 3551.264, 2021-12-31: 3948.26, 2022-03-31: 3860.529, 2022-06-30: 4127.378, 2022-09-30: 4390.457, 2022-12-31: 3913.72, 2023-03-31: 3916.156, 2023-06-30: 4053.05, 2023-09-30: 4901.565, 2023-12-31: 4407.765, 2024-03-31: 4199.913, 2024-06-30: 4376.076, 2024-09-30: 4416.947, 2024-12-31: 4552.086, 2025-03-31: 4279.298, 2025-06-30: 4626.451,

Description: ARMK Aramark Holdings

Aramark Holdings (NYSE:ARMK) is a leading provider of food and facilities services to various industries, including education, healthcare, business, sports, leisure, and corrections, operating globally. The companys diverse service portfolio includes food-related managed services, non-clinical support services, and facility management services, catering to a broad range of client needs.

Key Performance Indicators (KPIs) that can be used to evaluate Aramarks performance include revenue growth, operating margin, and client retention rates. The companys ability to expand its services and client base, particularly in the healthcare and education sectors, is crucial to its growth. Additionally, Aramarks focus on cost management and operational efficiency is essential in maintaining its competitive edge. With a strong presence in the US and international markets, the companys geographic diversification is a significant advantage.

From a financial perspective, Aramarks market capitalization and revenue indicate a substantial player in the industry. The companys return on equity (RoE) of 11.52% suggests a reasonable return for investors. Furthermore, the forward P/E ratio of 19.84 implies that the market expects earnings growth, potentially driven by the companys efforts to expand its services and improve operational efficiency.

To further analyze Aramarks performance, it would be essential to examine its revenue breakdown by segment, including the Food and Support Services United States and Food and Support Services International segments. This would provide insights into the companys geographic and service-based diversification. Additionally, analyzing the companys debt-to-equity ratio and interest coverage ratio would help assess its financial health and ability to meet its financial obligations.

ARMK Stock Overview

Market Cap in USD 10,280m
Sub-Industry Restaurants
IPO / Inception 2013-12-12

ARMK Stock Ratings

Growth Rating 53.6%
Fundamental 52.5%
Dividend Rating 54.1%
Return 12m vs S&P 500 -16.5%
Analyst Rating 4.43 of 5

ARMK Dividends

Dividend Yield 12m 1.11%
Yield on Cost 5y 2.28%
Annual Growth 5y 4.17%
Payout Consistency 98.8%
Payout Ratio 23.5%

ARMK Growth Ratios

Growth Correlation 3m -68.1%
Growth Correlation 12m 35.8%
Growth Correlation 5y 81.9%
CAGR 5y 13.53%
CAGR/Max DD 3y 0.49
CAGR/Mean DD 3y 1.84
Sharpe Ratio 12m 0.44
Alpha 0.11
Beta 0.416
Volatility 27.79%
Current Volume 1505.9k
Average Volume 20d 1659.8k
Stop Loss 36.4 (-3.1%)
Signal -0.84

Piotroski VR‑10 (Strict, 0-10) 1.5

Net Income (361.7m TTM) > 0 and > 6% of Revenue (6% = 1.07b TTM)
FCFTA 0.02 (>2.0%) and ΔFCFTA -0.53pp (YES ≥ +1.0pp, WARN ≥ +0.5pp)
NWC/Revenue 4.42% (prev -0.69%; Δ 5.11pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp)
CFO/TA 0.06 (>3.0%) and CFO 767.1m > Net Income 361.7m (YES >=105%, WARN >=100%)
Net Debt (6.11b) to EBITDA (1.31b) ratio: 4.68 <= 3.0 (WARN <= 3.5)
Current Ratio 1.29 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active)
Outstanding Shares last Quarter (267.2m) change vs 12m ago 0.23% (target <= -2.0% for YES)
Gross Margin 8.55% (prev 8.66%; Δ -0.11pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0)
Asset Turnover 138.4% (prev 142.5%; Δ -4.14pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0)
Interest Coverage Ratio 2.50 (EBITDA TTM 1.31b / Interest Expense TTM 336.2m) >= 6 (WARN >= 3)

Altman Z'' 0.95

(A) 0.06 = (Total Current Assets 3.53b - Total Current Liabilities 2.74b) / Total Assets 13.28b
(B) 0.03 = Retained Earnings (Balance) 393.7m / Total Assets 13.28b
(C) 0.07 = EBIT TTM 840.4m / Avg Total Assets 12.92b
(D) 0.02 = Book Value of Equity 245.1m / Total Liabilities 10.19b
Total Rating: 0.95 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D)

ValueRay F-Score (Strict, 0-100) 52.46

1. Piotroski 1.50pt = -3.50
2. FCF Yield 1.74% = 0.87
3. FCF Margin 1.57% = 0.39
4. Debt/Equity 2.06 = 0.68
5. Debt/Ebitda 4.87 = -2.50
6. ROIC - WACC (= 1.62)% = 2.02
7. RoE 11.83% = 0.99
8. Rev. Trend 46.73% = 3.50
9. EPS Trend 0.06% = 0.00

What is the price of ARMK shares?

As of September 18, 2025, the stock is trading at USD 37.56 with a total of 1,505,881 shares traded.
Over the past week, the price has changed by -2.31%, over one month by -4.52%, over three months by -6.62% and over the past year by -0.85%.

Is Aramark Holdings a good stock to buy?

Neither. Based on ValueRay´s Fundamental Analyses, Aramark Holdings is currently (September 2025) neither a good nor a bad stock to buy. It has a ValueRay Fundamental Rating of 52.46 and therefor a neutral outlook according to the companies health.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of ARMK is around 36.37 USD . This means that ARMK is currently overvalued and has a potential downside of -3.17%.

Is ARMK a buy, sell or hold?

Aramark Holdings has received a consensus analysts rating of 4.43. Therefore, it is recommended to buy ARMK.
  • Strong Buy: 8
  • Buy: 4
  • Hold: 2
  • Sell: 0
  • Strong Sell: 0

What are the forecasts/targets for the ARMK price?

Issuer Target Up/Down from current
Wallstreet Target Price 45.9 22.2%
Analysts Target Price 45.9 22.2%
ValueRay Target Price 39.2 4.5%

Last update: 2025-09-03 04:31

ARMK Fundamental Data Overview

Market Cap USD = 10.28b (10.28b USD * 1.0 USD.USD)
CCE Cash And Equivalents = 501.5m USD (Cash And Short Term Investments, last quarter)
P/E Trailing = 28.7574
P/E Forward = 17.8571
P/S = 0.5751
P/B = 3.3332
P/EG = 0.7055
Beta = 1.396
Revenue TTM = 17.87b USD
EBIT TTM = 840.4m USD
EBITDA TTM = 1.31b USD
Long Term Debt = 6.25b USD (from longTermDebt, last quarter)
Short Term Debt = 101.7m USD (from shortTermDebt, last quarter)
Debt = 6.36b USD (Calculated: Short Term 101.7m + Long Term 6.25b)
Net Debt = 6.11b USD (from netDebt column, last quarter)
Enterprise Value = 16.13b USD (10.28b + Debt 6.36b - CCE 501.5m)
Interest Coverage Ratio = 2.50 (Ebit TTM 840.4m / Interest Expense TTM 336.2m)
FCF Yield = 1.74% (FCF TTM 280.8m / Enterprise Value 16.13b)
FCF Margin = 1.57% (FCF TTM 280.8m / Revenue TTM 17.87b)
Net Margin = 2.02% (Net Income TTM 361.7m / Revenue TTM 17.87b)
Gross Margin = 8.55% ((Revenue TTM 17.87b - Cost of Revenue TTM 16.35b) / Revenue TTM)
Tobins Q-Ratio = 65.83 (Enterprise Value 16.13b / Book Value Of Equity 245.1m)
Interest Expense / Debt = 1.36% (Interest Expense 86.4m / Debt 6.36b)
Taxrate = 28.22% (103.0m / 364.9m)
NOPAT = 603.2m (EBIT 840.4m * (1 - 28.22%))
Current Ratio = 1.29 (Total Current Assets 3.53b / Total Current Liabilities 2.74b)
Debt / Equity = 2.06 (Debt 6.36b / last Quarter total Stockholder Equity 3.08b)
Debt / EBITDA = 4.87 (Net Debt 6.11b / EBITDA 1.31b)
Debt / FCF = 22.64 (Debt 6.36b / FCF TTM 280.8m)
Total Stockholder Equity = 3.06b (last 4 quarters mean)
RoA = 2.72% (Net Income 361.7m, Total Assets 13.28b )
RoE = 11.83% (Net Income TTM 361.7m / Total Stockholder Equity 3.06b)
RoCE = 9.03% (Ebit 840.4m / (Equity 3.06b + L.T.Debt 6.25b))
RoIC = 6.66% (NOPAT 603.2m / Invested Capital 9.06b)
WACC = 5.04% (E(10.28b)/V(16.64b) * Re(7.55%)) + (D(6.36b)/V(16.64b) * Rd(1.36%) * (1-Tc(0.28)))
Shares Correlation 3-Years: 84.85 | Cagr: 0.24%
Discount Rate = 7.55% (= CAPM, Blume Beta Adj.) -> floored to rf + ERP 8.05%
[DCF Debug] Terminal Value 79.68% ; FCFE base≈301.4m ; Y1≈333.2m ; Y5≈432.1m
Fair Price DCF = 28.57 (DCF Value 7.51b / Shares Outstanding 262.9m; 5y FCF grow 12.14% → 3.0% )
EPS Correlation: 0.06 | EPS CAGR: -6.41% | SUE: 0.0 | # QB: 0
Revenue Correlation: 46.73 | Revenue CAGR: 1.92% | SUE: N/A | # QB: None

Additional Sources for ARMK Stock

News: Wall Street Journal | Benzinga | Yahoo Finance
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle